$7.32
-0.1-1.35%
At Close: -
$7.29
-0.03-0.41%
After Hours: 4:22 PM EDT
15 minutes delayed
Bausch Health Companies
BHCNYSE
Bausch Health Companies (NYSE:BHC) Stock, Insider Trading Activity
Bausch Health Companies: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Bausch Health Companies Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Bausch Health Companies Inc
Institutional Shares Held
4.157B
| Mar 04, 2024 | Seana Carson | EVP, GENERAL COUNSEL | 116.98K | $9.87 | -$301.63K | GRANT | 30.55% | 499.90K | Feb 29 - Mar 04 | View |
| Dec 05, 2023 | Seana Carson | EVP, GENERAL COUNSEL | -1.91K | $7.36 | -$14.07K | SELL | -0.50% | 382.93K | Dec 01 - Dec 05 | View |
| Nov 06, 2023 | Seana Carson | EVP, GENERAL COUNSEL | -377.00 | $7.57 | -$2.86K | SELL | -0.10% | 384.84K | Nov 03 - Nov 06 | View |
| Sep 06, 2023 | Seana Carson | EVP, GENERAL COUNSEL | -58.02K | $8.34 | -$484.02K | SELL | -13.09% | 385.21K | Sep 05 - Sep 06 | View |
| Mar 01, 2023 | Seana Carson | EVP, GENERAL COUNSEL | -2.53K | $9.54 | -$24.18K | SELL | -0.70% | 359.19K | Feb 27 - Feb 28 | View |
| Apr 15, 2022 | Robert Spurr | U.S. PRESIDENT-PHARMA BUSINESS | -1.59K | $22.19 | -$35.39K | SELL | -1.73% | 90.51K | Apr 14 | View |
| Mar 16, 2022 | Robert Spurr | U.S. PRESIDENT-PHARMA BUSINESS | -4.85K | $22.20 | -$107.58K | SELL | -5.00% | 92.10K | Mar 15 | View |
| Mar 10, 2022 | Joseph F Gordon | PRES&CO-HEAD BAUSCH&LOMB/INT'L | -3.89K | $21.76 | -$84.62K | SELL | -4.01% | 93.14K | Mar 08 | View |
| Mar 04, 2022 | Joseph F Gordon | PRES&CO-HEAD BAUSCH&LOMB/INT'L | -11.08K | $23.37 | -$258.87K | SELL | -9.87% | 101.10K | Mar 02 | View |
| Mar 04, 2022 | Robert Spurr | U.S. PRESIDENT-PHARMA BUSINESS | 34.03K | $23.77 | $823.83K | GRANT | 50.80% | 101.02K | Mar 02 | View |
| Mar 02, 2022 | Joseph Gordon | PRES&CO-HEAD BAUSCH&LOMB/INT'L | 1.54K | $24.14 | -$381.59K | SELL-OPTIONS | 1.39% | 112.18K | Feb 26 - Mar 01 | View |
| Feb 17, 2022 | Robert Spurr | U.S. PRESIDENT-PHARMA BUSINESS | -3.25K | $25.02 | -$81.34K | SELL | -5.12% | 60.30K | Feb 15 | View |
| Jan 20, 2022 | Robert Spurr | U.S. PRESIDENT-PHARMA BUSINESS | -3.25K | $26.63 | -$86.57K | SELL | -4.87% | 63.55K | Jan 18 | View |
| Dec 02, 2021 | Steven D Miller | DIRECTOR | 60.00K | $24.23 | $1.45M | BUY | ∞ | 10.00K | Nov 30 | View |
| Aug 09, 2021 | Andrew C. von Eschenbach | DIRECTOR | 1.40K | $25.94 | $36.32K | BUY | 3.76% | 38.65K | Aug 05 | View |
| Aug 06, 2021 | Richard U. De Schutter | DIRECTOR | 10.00K | $25.01 | $250.12K | BUY | 3.12% | 330.91K | Aug 04 | View |
| Jun 15, 2021 | Sam Eldessouky | EVP & CHIEF FINANCIAL OFFICER | -17.00K | $31.68 | -$538.59K | SELL | -12.70% | 116.86K | Jun 11 | View |
| Jun 04, 2021 | Christina Ackermann | EVP AND GENERAL COUNSEL | 0.00 | $23.34 | -$2.06M | SELL-OPTIONS | 0.00% | 166.76K | Jun 02 | View |
| May 28, 2021 | Amy B Wechsler | DIRECTOR | -11.04K | $31.79 | -$350.81K | SELL | -10.09% | 98.33K | May 26 | View |
| Dec 08, 2020 | William D Humphries | — | 0.00 | $17.13 | -$626.29K | OPTION EXERCISE | 0.00% | 235.03K | Dec 04 | View |
| Nov 30, 2020 | William D Humphries | — | 0.00 | $17.01 | -$193.28K | OPTION EXERCISE | 0.00% | 235.03K | Nov 23 - Nov 27 | View |
| Sep 10, 2020 | William D Humphries | — | -5.67K | $16.17 | -$91.64K | SELL | -2.35% | 235.03K | Sep 08 | View |
| Jun 09, 2020 | ValueAct Holdings LPValueAct Capital Master Fund LPValueAct CoInvest Master Fund LPVA Partners I LLCValueAct Capital Management LPValueAct Capital Management LLCValueAct Holdings II LPValueAct Holdings GP LLC | — | 0.00 | $19.24 | $0.00 | PURCHASE | 0.00% | 17.93M | Jun 05 | View |
| May 14, 2020 | John Paulson | — | 5.00M | $16.65 | $83.25M | PURCHASE | 23.99% | 25.84M | May 12 - May 14 | View |
| Mar 16, 2020 | Thomas W. Ross, Sr. | — | 2.50K | $15.54 | $38.84K | PURCHASE | 3.26% | 79.24K | Mar 12 | View |
| Mar 11, 2020 | Christina Ackermann | — | 5.44K | $19.60 | $10.04K | GRANT OR AWARD | 6.00% | 96.03K | Mar 09 - Mar 10 | View |
| Mar 11, 2020 | Andrew C. von Eschenbach | — | 1.10K | $18.18 | $20.00K | PURCHASE | 6.30% | 18.57K | Mar 10 | View |
| Mar 11, 2020 | Richard U. De Schutter | — | 8.80K | $21.00 | $184.79K | PURCHASE | 176.00% | 13.80K | Mar 03 - Mar 10 | View |
| Sep 13, 2019 | Joseph C Papa | CHAIRMAN & CEO | 51.25K | $23.31 | $699.30K | BUY | 6.33% | 860.85K | Sep 13 | View |
| Aug 21, 2019 | Mark C McKenna | PRESIDENT, SALIX | -10.77K | $21.83 | -$235.22K | SELL | -34.17% | 20.76K | Aug 19 | View |
| Aug 20, 2019 | William D Humphries | PRESIDENT, ORTHO-DERMATOLOGICS | 61.41K | $21.18 | $650.14K | BUY | 52.48% | 178.42K | Aug 16 | View |
| Aug 13, 2019 | Christina Ackermann | EVP AND GENERAL COUNSEL | -11.20K | $22.41 | -$250.90K | SELL | -18.14% | 50.52K | Aug 09 - Aug 12 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.